Unknown

Dataset Information

0

Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase.


ABSTRACT: A novel Type II kinase inhibitor chemotype has been identified for maternal embryonic leucine zipper kinase (MELK) using structure-based ligand design. The strategy involved structural characterization of an induced DFG-out pocket by protein-ligand X-ray crystallography and incorporation of a slender linkage capable of bypassing a large gate-keeper residue, thus enabling design of molecules accessing both hinge and induced pocket regions. Optimization of an initial hit led to the identification of a low-nanomolar, cell-penetrant Type II inhibitor suitable for use as a chemical probe for MELK.

SUBMITTER: Johnson CN 

PROVIDER: S-EPMC4291807 | biostudies-other | 2015 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications


A novel Type II kinase inhibitor chemotype has been identified for maternal embryonic leucine zipper kinase (MELK) using structure-based ligand design. The strategy involved structural characterization of an induced DFG-out pocket by protein-ligand X-ray crystallography and incorporation of a slender linkage capable of bypassing a large gate-keeper residue, thus enabling design of molecules accessing both hinge and induced pocket regions. Optimization of an initial hit led to the identification  ...[more]

Similar Datasets

| S-EPMC4291735 | biostudies-literature
| S-EPMC6717526 | biostudies-literature
| S-EPMC3724675 | biostudies-literature
| S-EPMC6398941 | biostudies-literature
| S-EPMC6669820 | biostudies-literature
| S-EPMC4270240 | biostudies-literature
| S-EPMC7154462 | biostudies-literature
| S-EPMC4323011 | biostudies-literature
| S-EPMC4113179 | biostudies-literature
| S-EPMC10281291 | biostudies-literature